Icon times
Deepak Nitrite Q4 Results | Yadnya Investment Academy

Deepak Nitrite Q4 Results | Yadnya Investment Academy

Published on 20 May 2021 Views 203 Comments 4

Financial results for Q4

Standalone Q4FY21 results

  • The total income for Q4FY21 stood at Rs. 529 crores as compared to Rs. 526 crores in Q4FY20, a small growth of 0.5%
  • The EBITDA for Q4FY21 decreased by (14.3%) to Rs. 158 crores from Rs. 185 crores in Q4FY20.
  • PBT reduced to Rs. 137 crores in Q4FY21 from Rs. 160 Cr in Q4FY20, a fall of (14.1%).
  • PAT also reduced from Rs. 116 crores in Q4FY21 from Rs. 101 Crores in Q4FY20, a fall of (13%).

Consolidated Q4FY21 results

  • Total Income surged by 38.9% from Rs. 1058 Crores in Q4FY20 to Rs. 1469 Crores in Q4FY21.
  • On similar lines, EBITDA went up by 74.3% from Rs. 264 Crores (21% margin) in Q4FY20 to Rs. 461 Crores (31% margin) in Q4FY21.
  • Higher EBITDA is a result of favourable pricing environment, controlled operating leverage & higher plant efficiency.
  • PBT for Q4FY20 stood at Rs. 201 Crores & for Q4FY21 at Rs. 390 Crores revealing a tremendous growth of 94.1%.
  • This tremendous growth in PBT is due to reduced interest cost on account of reduction of debt by the company.
  • PAT from Rs. 172 Crores in Q4FY20 went on to increase by 68.4% YoY to stand at Rs. 290 Crores in Q4FY21. 
  • PAT increased on account of improved operational & financial efficiency.
  • Company has recorded supernormal profit on account of increased prices of DASDA.

Consolidated Segmental Performance

  • Revenue from Basic Chemicals segment were recorded at Rs. 245 crores in Q4FY21 & in Q4FY20 at Rs. 226 crores, thus, growth by 9%.
  • This higher revenue was reported due to great growth in volume YoY as there was sharp rebound in end user industries despite an increase in raw material prices.
  • Revenue from Fine & Specialty chemicals went up from Rs. 158 crores in Q4FY20 by 30% to stand at Rs. 206 crores in Q4FY21.
  • This boost was recorded on account of increased volume by 15%, increased demand for the product & better pricing of the segment products on YoY basis.
  • Revenue from Performance products segment came down by (44%) from Rs. 154 crores in Q4FY20 to Rs. 87 crores in Q4FY21.
  • Revenue from Phenolics business surged by 77% from Rs. 531 crores in Q4FY20 to Rs. 938 crores in Q4FY21.
  • Reasons attributed for this increase are increased demand, increased capacity utilisation & improved prices.

Financial results for FY21

Standalone FY21 results

  • Total Income for FY21 stood at Rs. 1823 crores as compared to Rs. 2237 crores in FY20, recording a fall of (18.5%) YoY.
  • EBITDA reduced by (31.7%) from Rs. 804 Crores in FY20 to Rs. 550 crores in FY20.
  • PBT from Rs. 706 Crores in FY20 fell by (32.2%) to Rs. 479 crores in FY21.
  • PAT stood at Rs. 544 crores in FY20 & then fell by (34.8%) to stand at Rs. 355 crores in FY21.

Consolidated FY21 results

  • The Total Income of FY21 increased by small 2.7% from Rs. 4265 Crores in FY20 to Rs. 4381 crores in FY21.
  • Increased revenue is result of optimal utilisation of the plants by the company & by further exploring the domestic & international markets.
  • EBITDA grew by 19.6% from Rs. 1061 crores in FY20 to Rs. 1269 crores in FY21.
  • PBT from Rs. 806 crores in FY20 went up by 29.2% to stand at Rs. 1042 crores in FY21.
  • PAT witnessed a growth of 27% from Rs. 611 crores in FY20 to Rs. 776 crores in FY21.
  • Overall results are satisfactory despite of the fact that starting one month of the FY was under Covid-19 lockdown restriction.

Consolidated Segmental Performance

  • Revenue from Basic Chemicals segment for full FY21 fell to Rs. 760 crores from Rs. 940 crores in FY20, a fall of (19%).
  • Revenue from Fine & Speciality chemicals witnessed a growth of 31% from Rs. 586 crores in FY20 to Rs. 767 crores in FY21.
  • Performance product segments’ revenue declined by (60%) from Rs. 767 crores in FY20 to Rs. 304 crores.
  • Revenue from Phenolics business increased by 28% from Rs. 2001 crores in FY20 to Rs. 2561 crores in FY21.

Dividend

  • The Board of Directors recommended a final dividend of Rs. 5.5 per share for FY21.

 

Attachments
File Name
private article suscription area icon

You like to know more. We like that!

Please subscribe Model Portfolio Plan to get access of all premium model portfolio articles Only at Rs 7499/Year.

Please login to view this free article.

This blog is available only for logged in users, please register and get access to view this article.

LATEST UPDATE

premium Premium
free Free
Read More

REPORTS


Chat on WhatsApp
Caret UP Arrow
InvestYadnya Support
Typically replies in minutes
InvestYadnya Support
Hi there
Welcome to InvestYadnya.
We are available to assist you on WhatsApp.
Please click on the button below to chat with us.
(10 AM to 7 PM IST)
16:10
Chat with InvestYadnya